Niacin and Nicotinamide: Two Forms, One Vitamin, Different Effects

Abstract

Vitamin B3 comes in forms that behave differently enough to confuse people who have read one thing and bought another. The flushing that niacin is famous for comes from one of them and not the others.

This article sets out what separates nicotinic acid, nicotinamide, nicotinamide riboside and nicotinamide mononucleotide, and where the safety ceiling sits for each — because the doses in the safety literature are enormous compared with what any supplement supplies.

Boost contains niacinamide at 20 mg, which is 125 per cent of the nutrient reference value. It is also one of the few ingredients in our range with an authorised health claim, and this is our account of what that claim does and does not cover.

1.Four Names, One Vitamin

The B3 family, as set out in a 2025 review by Luca Camillo, Elisa Zavattaro and Paola Savoia at the University of Eastern Piedmont, comprises nicotinic acid, nicotinamide, nicotinamide riboside and nicotinamide mononucleotide.

All of them end up feeding the same molecule: nicotinamide adenine dinucleotide, NAD, which every cell uses in energy metabolism and which we covered at length in our series on NAD and the ageing brain. What differs is the route in, and the route determines the side effects.

Nicotinamide is what appears on a label as niacinamide. It is the form in Boost and the form in most multivitamins.

Nicotinic acid is what people usually mean by niacin, and it is the one used at gram-scale doses for lipid management under medical supervision.

2.Where the Flushing Comes From

The reddening, heat and prickling that follows a large dose of niacin is a real pharmacological effect, and it is specific to nicotinic acid. Nicotinamide does not produce it.

This matters practically. Someone who reads that niacin causes flushing and then takes niacinamide will not experience it, and may conclude the product is inert. Someone who reads that niacinamide is well tolerated and then takes nicotinic acid at a comparable dose may have an alarming afternoon.

The distinction is a genuine difference in what the molecules do, not a labelling convention. Camillo and colleagues summarise the comparison plainly: against the other B3 forms, nicotinamide shows excellent tolerability, with fewer adverse effects.

3.What the Safety Literature Actually Tested

The reference work on high-dose nicotinamide is a review by Mikael Knip, Isabel Douek, Polly Bingley, Edwin Gale and colleagues, published in Diabetologia in 2000. It exists because nicotinamide was being trialled at very large doses as a possible intervention to prevent type 1 diabetes, which required someone to establish what such doses do.

That context is the useful part. The safety data were generated at doses in the gram range, sustained over months to years — orders of magnitude above what a supplement contains.

Camillo and colleagues put the tolerability ceiling for nicotinamide at up to three grams a day, with rare adverse effects even over prolonged treatment. Three grams is one hundred and fifty times the amount in a daily dose of Boost.

This is worth stating clearly in both directions. It means the nicotinamide in an ordinary supplement sits nowhere near any established boundary. It also means that nothing about that reassurance transfers to gram-scale self-dosing, which belongs with a doctor — the trials that established these figures were monitored, and liver function is the thing they were monitoring.

4.The Newer Forms

Nicotinamide riboside and nicotinamide mononucleotide are the forms sold on longevity claims, and they are considerably less well established than the two older ones.

A 2023 review in Advances in Nutrition by Qin Song and colleagues assessed the safety and anti-ageing effects of nicotinamide mononucleotide across human clinical trials. Its framing is worth noting — an update on safety and effects, in a literature young enough to need updating.

Our NAD series covered the substance of these claims and found the honest position to be that raising NAD in humans is achievable and that what follows from doing so is much less clear. Nothing here changes that.

For present purposes the point is narrower: someone comparing prices between niacinamide and NMN is not comparing two grades of the same thing. They are comparing an established vitamin form with an evidence base going back decades against a newer molecule whose human literature is still being summarised.

5.What May Be Claimed

Niacin is one of the nutrients with an authorised health claim in the European Union under Regulation (EU) 432/2012, and the permitted wording is: "Niacin contributes to the reduction of tiredness and fatigue."

Three things about that sentence deserve attention, because they are what separates a claim from a promise.

It says contributes, not causes or eliminates. It attaches to the nutrient, not to any product containing it. And the claim exists because niacin is a vitamin with a defined role in energy metabolism, which means it describes what happens when intake is adequate rather than what happens when intake is increased above adequate.

The tiredness in that claim is also not the tiredness most people mean. It is the fatigue associated with insufficient intake of the nutrient — a different construct from the mental fatigue that builds over an afternoon of demanding work, which we covered separately and which no vitamin claim addresses.

Editorial Comment

Boost supplies niacinamide at 20 mg, or 125 per cent of the nutrient reference value, and we quote the authorised wording above because it is one of the few things in our range we are permitted to say and can support.

We would rather a reader understood its limits than took it as more than it is. It is a statement about a vitamin doing its ordinary job. It is not a claim that our drops will make anyone feel less tired, and we are not making that claim.

There is no authorised claim connecting any B3 form to cognition, alertness or concentration, so we make none.

Fatigue that persists despite adequate rest deserves a cause rather than a supplement. Iron deficiency, thyroid disease, sleep apnoea, depression and coeliac disease all present this way, all are identifiable with ordinary tests, and several are straightforwardly treatable. Finding the reason is worth more than anything on this page.